Cargando…

Valine metabolites analysis in ECHS1 deficiency

Short-chain enoyl-CoA hydratase (ECHS1) is involved in amino acid and fatty acid catabolism in mitochondria and its deficiency causes Leigh syndrome or exercise-induced dystonia. More than 60 patients with this condition have been reported till date. The accumulation of intermediate metabolites of v...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwajima, Mari, Kojima, Karin, Osaka, Hitoshi, Hamada, Yusuke, Jimbo, Eriko, Watanabe, Miyuki, Aoki, Shiho, Sato-Shirai, Ikuko, Ichimoto, Keiko, Fushimi, Takuya, Murayama, Kei, Ohtake, Akira, Kohda, Masakazu, Kishita, Yoshihito, Yatsuka, Yukiko, Uchino, Shumpei, Mimaki, Masakazu, Miyake, Noriko, Matsumoto, Naomichi, Okazaki, Yasushi, Ogata, Tomomi, Yamagata, Takanori, Muramatsu, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507190/
https://www.ncbi.nlm.nih.gov/pubmed/34667719
http://dx.doi.org/10.1016/j.ymgmr.2021.100809
_version_ 1784581802302636032
author Kuwajima, Mari
Kojima, Karin
Osaka, Hitoshi
Hamada, Yusuke
Jimbo, Eriko
Watanabe, Miyuki
Aoki, Shiho
Sato-Shirai, Ikuko
Ichimoto, Keiko
Fushimi, Takuya
Murayama, Kei
Ohtake, Akira
Kohda, Masakazu
Kishita, Yoshihito
Yatsuka, Yukiko
Uchino, Shumpei
Mimaki, Masakazu
Miyake, Noriko
Matsumoto, Naomichi
Okazaki, Yasushi
Ogata, Tomomi
Yamagata, Takanori
Muramatsu, Kazuhiro
author_facet Kuwajima, Mari
Kojima, Karin
Osaka, Hitoshi
Hamada, Yusuke
Jimbo, Eriko
Watanabe, Miyuki
Aoki, Shiho
Sato-Shirai, Ikuko
Ichimoto, Keiko
Fushimi, Takuya
Murayama, Kei
Ohtake, Akira
Kohda, Masakazu
Kishita, Yoshihito
Yatsuka, Yukiko
Uchino, Shumpei
Mimaki, Masakazu
Miyake, Noriko
Matsumoto, Naomichi
Okazaki, Yasushi
Ogata, Tomomi
Yamagata, Takanori
Muramatsu, Kazuhiro
author_sort Kuwajima, Mari
collection PubMed
description Short-chain enoyl-CoA hydratase (ECHS1) is involved in amino acid and fatty acid catabolism in mitochondria and its deficiency causes Leigh syndrome or exercise-induced dystonia. More than 60 patients with this condition have been reported till date. The accumulation of intermediate metabolites of valine is assumed to be responsible for the cytotoxicity. Since protein restriction, including valine reportedly improves neurological symptoms, it is essential to consider the possible incidence of and diagnose ECHS1 syndrome in the earlier stages. This study reported the liquid chromatography with tandem mass spectrometry (LC-MS/MS) urine and plasma metabolite analysis in six cases, including four new cases with ECHS1 deficiency. The values of urine cysteine/cysteamine conjugates from valine metabolites, S-(2-carboxypropyl) cysteine/cysteamine from methacrylyl-CoA, and S-(2-carboxyethyl) cysteine/cysteamine from acryloyl-CoA were separated between six patients and six normal controls. The LC-MS/MS analysis revealed that these metabolites can be used for the early diagnosis and evaluation of diet therapy.
format Online
Article
Text
id pubmed-8507190
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85071902021-10-18 Valine metabolites analysis in ECHS1 deficiency Kuwajima, Mari Kojima, Karin Osaka, Hitoshi Hamada, Yusuke Jimbo, Eriko Watanabe, Miyuki Aoki, Shiho Sato-Shirai, Ikuko Ichimoto, Keiko Fushimi, Takuya Murayama, Kei Ohtake, Akira Kohda, Masakazu Kishita, Yoshihito Yatsuka, Yukiko Uchino, Shumpei Mimaki, Masakazu Miyake, Noriko Matsumoto, Naomichi Okazaki, Yasushi Ogata, Tomomi Yamagata, Takanori Muramatsu, Kazuhiro Mol Genet Metab Rep Research Paper Short-chain enoyl-CoA hydratase (ECHS1) is involved in amino acid and fatty acid catabolism in mitochondria and its deficiency causes Leigh syndrome or exercise-induced dystonia. More than 60 patients with this condition have been reported till date. The accumulation of intermediate metabolites of valine is assumed to be responsible for the cytotoxicity. Since protein restriction, including valine reportedly improves neurological symptoms, it is essential to consider the possible incidence of and diagnose ECHS1 syndrome in the earlier stages. This study reported the liquid chromatography with tandem mass spectrometry (LC-MS/MS) urine and plasma metabolite analysis in six cases, including four new cases with ECHS1 deficiency. The values of urine cysteine/cysteamine conjugates from valine metabolites, S-(2-carboxypropyl) cysteine/cysteamine from methacrylyl-CoA, and S-(2-carboxyethyl) cysteine/cysteamine from acryloyl-CoA were separated between six patients and six normal controls. The LC-MS/MS analysis revealed that these metabolites can be used for the early diagnosis and evaluation of diet therapy. Elsevier 2021-10-09 /pmc/articles/PMC8507190/ /pubmed/34667719 http://dx.doi.org/10.1016/j.ymgmr.2021.100809 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Paper
Kuwajima, Mari
Kojima, Karin
Osaka, Hitoshi
Hamada, Yusuke
Jimbo, Eriko
Watanabe, Miyuki
Aoki, Shiho
Sato-Shirai, Ikuko
Ichimoto, Keiko
Fushimi, Takuya
Murayama, Kei
Ohtake, Akira
Kohda, Masakazu
Kishita, Yoshihito
Yatsuka, Yukiko
Uchino, Shumpei
Mimaki, Masakazu
Miyake, Noriko
Matsumoto, Naomichi
Okazaki, Yasushi
Ogata, Tomomi
Yamagata, Takanori
Muramatsu, Kazuhiro
Valine metabolites analysis in ECHS1 deficiency
title Valine metabolites analysis in ECHS1 deficiency
title_full Valine metabolites analysis in ECHS1 deficiency
title_fullStr Valine metabolites analysis in ECHS1 deficiency
title_full_unstemmed Valine metabolites analysis in ECHS1 deficiency
title_short Valine metabolites analysis in ECHS1 deficiency
title_sort valine metabolites analysis in echs1 deficiency
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507190/
https://www.ncbi.nlm.nih.gov/pubmed/34667719
http://dx.doi.org/10.1016/j.ymgmr.2021.100809
work_keys_str_mv AT kuwajimamari valinemetabolitesanalysisinechs1deficiency
AT kojimakarin valinemetabolitesanalysisinechs1deficiency
AT osakahitoshi valinemetabolitesanalysisinechs1deficiency
AT hamadayusuke valinemetabolitesanalysisinechs1deficiency
AT jimboeriko valinemetabolitesanalysisinechs1deficiency
AT watanabemiyuki valinemetabolitesanalysisinechs1deficiency
AT aokishiho valinemetabolitesanalysisinechs1deficiency
AT satoshiraiikuko valinemetabolitesanalysisinechs1deficiency
AT ichimotokeiko valinemetabolitesanalysisinechs1deficiency
AT fushimitakuya valinemetabolitesanalysisinechs1deficiency
AT murayamakei valinemetabolitesanalysisinechs1deficiency
AT ohtakeakira valinemetabolitesanalysisinechs1deficiency
AT kohdamasakazu valinemetabolitesanalysisinechs1deficiency
AT kishitayoshihito valinemetabolitesanalysisinechs1deficiency
AT yatsukayukiko valinemetabolitesanalysisinechs1deficiency
AT uchinoshumpei valinemetabolitesanalysisinechs1deficiency
AT mimakimasakazu valinemetabolitesanalysisinechs1deficiency
AT miyakenoriko valinemetabolitesanalysisinechs1deficiency
AT matsumotonaomichi valinemetabolitesanalysisinechs1deficiency
AT okazakiyasushi valinemetabolitesanalysisinechs1deficiency
AT ogatatomomi valinemetabolitesanalysisinechs1deficiency
AT yamagatatakanori valinemetabolitesanalysisinechs1deficiency
AT muramatsukazuhiro valinemetabolitesanalysisinechs1deficiency